key: cord-0725276-8r5afdqg
authors: Lo, Angela; Mir, Adnan; Sami, Naveed
title: Letter in Reply: Alopecia areata after SARS-CoV-2 vaccination
date: 2022-05-07
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2022.04.022
sha: 064e61900d8931bb7db65485c751a5f9f6ab29fd
doc_id: 725276
cord_uid: 8r5afdqg

nan

concerning the development of alopecia areata following SARS-CoV-2 vaccination to be informative. 16 We want to reinforce these findings through a patient encounter where alopecia areata (AA) developed 17

in an elderly woman after receiving the SARS-CoV-2 vaccine and was successfully treated with 18

topical tacrolimus with minoxidil, as well as intralesional triamcinolone acetonide. 19

A 61-year-old-woman with no history of systemic disease presented for evaluation of patches of 20 alopecia one week after receiving the second dose of the Pfizer SARS-CoV-2 vaccine in April 2021. 21

She denied any other symptoms, cutaneous or systemic, after the vaccination. Physical examination at 22

presentation revealed four areas of patchy hair loss localized to the scalp ( Fig 1A) . Two punch 23 biopsies were performed, showing follicular miniaturization, a marked catagen/telogen shift, and a 24 peribulbar, predominantly lymphocytic inflammatory infiltrate, confirming the diagnosis of alopecia 25 areata (Figs 2A, 2B) . The patient was started on treatment with topical fluocinonide solution and 26 topical minoxidil for one month followed by topical tacrolimus ointment and minoxidil 5% solution 27

for an additional five months. Intralesional triamcinolone acetonide 2.5 mg/cc was administered once 28 a month for 3 consecutive months. 29 Improvement was seen one month after treatment with full hair growth in all 4 areas at 4-months 30

follow-up ( Fig 1B) . No relapse in hair loss was observed after the patient received the Pfizer booster 31 vaccine in October 2021 or at 8 months follow up in December 2021. 32

Alopecia areata is predominantly an idiopathic disease of the younger age group (21-40 years). 2 33

However, the possible connection between vaccines and autoimmune diseases including alopecia has 34 long been suspected. 3 

Alopecia areata after sars-cov-2 vaccination

Alopecia areata. An evaluation of 736 patients

Vaccination and induction of autoimmune diseases